1. Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”

   • Stephanos J. Hadziyannis

   Editorial 02 June 2007 Pages: 281 - 284

2. Towards a rational treatment strategy for chronic hepatitis B

   • Yun-Fan Liaw

   Editorial Notes 06 June 2007 Pages: 285 - 286

3. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease

   • Tatsuki Ichikawa
   • Kazuhiko Nakao
   • Katsumi Eguchi

   Original Paper 01 June 2007 Pages: 287 - 294

   

4. Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion

   • Yukihiro Koike
   • Haruhiko Yoshida
   • Masao Omata

   Original Paper 08 June 2007 Pages: 295 - 301

   

5. Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A

   • Masaru Moriyama
   • Naoya Kato
   • Masao Omata

   Original Paper 31 May 2007 Pages: 302 - 310

   

6. Spontaneous relapse of hepatitis in inactive HBsAg carriers

   • Chia-Ming Chu
   • Yun-Fan Liaw

   Original Paper 09 June 2007 Pages: 311 - 315

   

7. Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies

   • George Lau
   • Patrick Marcellin
   • Marion Peters

   Original Paper 06 June 2007 Pages: 316 - 325

   

8. The 17th APASL Annual Meeting 2007 at Kyoto

   Events 06 June 2007 Pages: 326 - 342